Evidence map›Paper›PMID 34689214›Full record

ArticleDiabetologia2022

Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver.

Rashmi B Prasad, Olof Asplund, Sharvari R Shukla, Rucha Wagh, Pooja Kunte, Dattatrey Bhat, Malay Parekh, Meet Shah, Sanat Phatak, Annemari Käräjämäki and 7 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Genetic basis of Asian diabetes.Journal of diabetes investigation · 2026
    Review
  7. Article
  8. Article
  9. Type 2 diabetes mellitus.Nature reviews. Disease primers · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Diabetic retinal disease.Nature reviews. Disease primers · 2025
    Review
  17. Prediabetes.Nature reviews. Disease primers · 2025
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Rashmi B PrasadDepartment of Clinical Sciences, Diabetes and Endocrinology, CRC, Lund University, Malmö, Sweden. rashmi.prasad@med.lu.se.ORCID 0000-0002-4400-6741
Olof AsplundDepartment of Clinical Sciences, Diabetes and Endocrinology, CRC, Lund University, Malmö, Sweden.ORCID 0000-0001-8449-8907
Sharvari R ShuklaDiabetes Unit, Kamalnayan Bajaj Diabetology Research Centre, King Edward Memorial Hospital and Research Centre, Pune, India.ORCID 0000-0002-7029-5532
Rucha WaghDiabetes Unit, Kamalnayan Bajaj Diabetology Research Centre, King Edward Memorial Hospital and Research Centre, Pune, India.ORCID 0000-0002-4911-731X
Pooja KunteDiabetes Unit, Kamalnayan Bajaj Diabetology Research Centre, King Edward Memorial Hospital and Research Centre, Pune, India.ORCID 0000-0002-1943-9174
Dattatrey BhatDiabetes Unit, Kamalnayan Bajaj Diabetology Research Centre, King Edward Memorial Hospital and Research Centre, Pune, India.
Malay ParekhDia Care - Diabetes Hormone Clinic, Ahmedabad, India.ORCID 0000-0003-0233-0081
Meet ShahDia Care - Diabetes Hormone Clinic, Ahmedabad, India.ORCID 0000-0003-3085-4413
Sanat PhatakDiabetes Unit, Kamalnayan Bajaj Diabetology Research Centre, King Edward Memorial Hospital and Research Centre, Pune, India.ORCID 0000-0002-3548-9956
Annemari KäräjämäkiDepartment of Primary Health Care, Vaasa Central Hospital, Vaasa, Finland.ORCID 0000-0001-9115-5611
Anupam DattaAssam Medical College and Hospital, Dibrugarh, India.ORCID 0000-0001-9520-5196
Sanjeeb KakatiAssam Medical College and Hospital, Dibrugarh, India.ORCID 0000-0003-4087-6042
Tiinamaija TuomiDepartment of Clinical Sciences, Diabetes and Endocrinology, CRC, Lund University, Malmö, Sweden.ORCID 0000-0002-8306-6202
Banshi SabooDia Care - Diabetes Hormone Clinic, Ahmedabad, India.ORCID 0000-0001-7293-8864
Emma AhlqvistDepartment of Clinical Sciences, Diabetes and Endocrinology, CRC, Lund University, Malmö, Sweden.ORCID 0000-0002-6513-2384
Leif GroopDepartment of Clinical Sciences, Diabetes and Endocrinology, CRC, Lund University, Malmö, Sweden.ORCID 0000-0002-0187-3263
Chittaranjan S YajnikDiabetes Unit, Kamalnayan Bajaj Diabetology Research Centre, King Edward Memorial Hospital and Research Centre, Pune, India. csyajnik@gmail.com.ORCID 0000-0002-2911-2378
King Edward Memorial Hospital Research Centre · INLund University · SEDiabetes Care & Hormone Clinic · INAssam Medical College · INSymbiosis International University · INUniversity of Helsinki · FIVaasa Central Hospital · FI

Funding

Wellcome Trust
6 · The paper itself

Abstract

aim/hypothesisFive subgroups were described in European diabetes patients using a data driven machine learning approach on commonly measured variables. We aimed to test the applicability of this phenotyping in Indian individuals with young-onset type 2 diabetes.

methodsWe applied the European-derived centroids to Indian individuals with type 2 diabetes diagnosed before 45 years of age from the WellGen cohort (n = 1612). We also applied de novo k-means clustering to the WellGen cohort to validate the subgroups. We then compared clinical and metabolic-endocrine characteristics and the complication rates between the subgroups. We also compared characteristics of the WellGen subgroups with those of two young European cohorts, ANDIS (n = 962) and DIREVA (n = 420). Subgroups were also assessed in two other Indian cohorts, Ahmedabad (n = 187) and PHENOEINDY-2 (n = 205).

resultsBoth Indian and European young-onset type 2 diabetes patients were predominantly classified into severe insulin-deficient (SIDD) and mild obesity-related (MOD) subgroups, while the severe insulin-resistant (SIRD) and mild age-related (MARD) subgroups were rare. In WellGen, SIDD (53%) was more common than MOD (38%), contrary to findings in Europeans (Swedish 26% vs 68%, Finnish 24% vs 71%, respectively). A higher proportion of SIDD compared with MOD was also seen in Ahmedabad (57% vs 33%) and in PHENOEINDY-2 (67% vs 23%). Both in Indians and Europeans, the SIDD subgroup was characterised by insulin deficiency and hyperglycaemia, MOD by obesity, SIRD by severe insulin resistance and MARD by mild metabolic-endocrine disturbances. In WellGen, nephropathy and retinopathy were more prevalent in SIDD compared with MOD while the latter had higher prevalence of neuropathy. CONCLUSIONS /

interpretationOur data identified insulin deficiency as the major driver of type 2 diabetes in young Indians, unlike in young European individuals in whom obesity and insulin resistance predominate. Our results provide useful clues to pathophysiological mechanisms and susceptibility to complications in type 2 diabetes in the young Indian population and suggest a need to review management strategies.

Indexed as

Diabetes Mellitus, Type 2Insulin ResistanceHumansIndiaInsulinObesityInsulinEuropeIndiaInsulin deficiencySubgroupsType 2 diabetesYoung-onset type 2 diabetes

Identifiers

PMID34689214
PMCPMC8660725
OpenAlexW3210711974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.